New Services Support Continued Development of Iute’s Digital Ecosystem

Tallinn, Estonia, 11 June 2026.

Iute Group, a leading European personal finance group, has partnered with Further, a global provider of Second Medical Opinion and Precision CancerCare services. The collaboration expands Iute Affinity’s insurance offering and supports the continued development of Iute Group’s digital ecosystem. The new services complement Iute Affinity’s existing insurance portfolio and are expected to be introduced across Iute’s markets in Albania, North Macedonia, Moldova, and Bulgaria during the third quarter of 2026.

Insurance has become one of the fastest-growing components of Iute’s business. Today, more than 21% of Iute’s over 247,000 active customers use insurance solutions. In the first quarter of 2026, insurance intermediation revenue increased by 71.4% year-over-year. The introduction of specialized healthcare services complements Iute’s insurance offering in markets representing a population of more than 60 million people. The new services further strengthen Iute’s ability to expand value-added offerings within its digital ecosystem and support the continued development of its insurance business.

Alma Ribanovic, CEO of Iute Affinity, said: “Insurance has become an increasingly important part of our ecosystem. Through our collaboration with Further, we are expanding our offering with services that provide customers access to internationally recognized medical expertise and advanced diagnostic capabilities. This strengthens our value proposition and allows us to offer additional protection solutions across our markets.”

The partnership gives customers access to two specialized healthcare services. Further’s Second Medical Opinion service enables people facing serious illnesses to have their diagnosis and treatment plans independently reviewed by leading international medical experts. In addition, Further’s Precision CancerCare service combines molecular profiling, advanced laboratory analysis, and expert medical review to create highly personalized cancer treatment recommendations.

Frank Ahedo, CEO of Further, commented: “At Further, we focus on connecting patients with the right expertise at the right moment, especially when facing complex and serious conditions. Through our collaboration with Iute, we can now support more people across Southeast Europe with trusted second opinions and advanced cancer diagnostics.”